LABTRACE.ORG BETA LIVE
256 source polls this hour 39 279 articles collected last article 5m ago 633 events on 2+ sources 0 embeddings/h feed queue 0 lag 352.2s
← health
LT-004708 / first seen 2026-08-07 16:43 / last activity 34d ago solid / under-covered

The tumour microenvironment influences long-term tamoxifen benefit in postmenopausal ER+/HER2− breast cancer patients: a secondary analysis of the randomised Stockholm Tamoxifen (STO-3) trial

measurement

heat
2 / 100 (raw 0.0)
velocity
0.0 independent sources per hour
solidity
80 / 100
sources
1 total, 1 independent
domain span
1 domain covered it

primary source

title
The tumour microenvironment influences long-term tamoxifen benefit in postmenopausal ER+/HER2− breast cancer patients: a secondary analysis of the randomised Stockholm Tamoxifen (STO-3) trial
venue
status
peer-reviewed
doi
10.1186/s12916-026-05091-5
published
2026-08-05

media coverage / 1 outlets